Hims & Hers Health to acquire Australia's Eucalyptus for up to $1.15 billion [CNBC]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: CNBC
Eucalyptus in a deal valued ?at up ?to $1.15 billion, ?as the U.S. telehealth platform seeks to broaden its personalized care business into ?new ?international markets. The deal would ?give Hims & Hers a foothold in Australia and Japan while deepening its presence in ?the United Kingdom, Germany, and Canada through partnerships with established regional ?operators. Eucalyptus operates several consumer-focused brands globally, including weight-loss program Juniper and men's telehealth brand Pilot, and ?has served more than 775,000 customers, according ?to Hims & Hers. Hims & Hers ?is currently facing a lawsuit from Danish drugmaker Novo Nordisk after a ?crackdown from the U.S. Food and Drug Administration ?forced it to ?abruptly withdraw its newly launched $49 copy of Novo's blockbuster weight-loss pill Wegovy. The ?deal is ?expected to close in the middle of calendar year 2026. About $240 million will be payable in cash upon closing of ?the acquisition, Hims & Hers ?said.
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk's Wegovy® Pill Achieves Strong First-Month Uptake, Signaling Expanding Demand for Oral GLP-1s in Obesity [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk A/S: Notice for the Annual General Meeting of Novo Nordisk A/S [Yahoo! Finance]Yahoo! Finance
- Healthy Returns: FDA chief Marty Makary on compounded GLP-1s, vaccines and China [CNBC]CNBC
- What Is HIMS Worth Without GLP-1? Earnings Preview [Seeking Alpha]Seeking Alpha
- The GLP-1 treatment you want is in a convenient daily pill [USA TODAY]USA TODAY
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 2/20/26 - Form 6-K
- 2/17/26 - Form 6-K
- 2/11/26 - Form 6-K
- NVO's page on the SEC website